Results 91 to 100 of about 598 (175)

Tamoxifen, aminoglutethimide and danazol: effect of therapy on hormones in post-menopausal patients with breast cancer. [PDF]

Br J Cancer, 1982
Coombes RC, Powles TJ, Rees LH, Ratcliffe WA, Nash AG, Henk M, Ford HT, Gazet JC, Neville AM.   +8 more
europepmc   +1 more source

Antagonism of fludrocortisone by spironolactone and canrenone. [PDF]

Br J Clin Pharmacol, 1976
Huston GJ, Turner P.
europepmc   +1 more source

Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease. [PDF]

Br Med J (Clin Res Ed), 1987
Panahy C, Puddefoot JR, Anderson E, Vinson GP, Berry CL, Turner MJ, Brown CL, Goode AW.   +7 more
europepmc   +1 more source

Effect of spironolactone and potassium canrenoate on cytosolic and nuclear androgen and estrogen receptors of rat liver. [PDF]

Gastroenterology, 1987
Francavilla A, Di Leo A, Eagon PK, Polimeno L, Guglielmi F, Fanizza G, Barone M, Starzl TE.   +7 more
europepmc   +1 more source

Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine. [PDF]

Br Med J (Clin Res Ed), 1983
Paterson CR, Feely J.
europepmc   +1 more source

The interaction of canrenone with oestrogen and progesterone receptors in human uterine cytosol. [PDF]

Br J Clin Pharmacol, 1983
Fernandez MD, Carter GD, Palmer TN.
europepmc   +1 more source

The selective antimuscarinic action of stercuronium. [PDF]

Br J Pharmacol, 1980
Li CK, Mitchelson F.
europepmc   +1 more source